Puma Biotechnology, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PBYI research report →
Companywww.pumabiotechnology.com
Puma Biotechnology, Inc. , a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors.
- CEO
- Alan H. Auerbach
- IPO
- 2012
- Employees
- 172
- HQ
- Los Angeles, CA, US
Price Chart
Valuation
- Market Cap
- $355.79M
- P/E
- 14.58
- P/S
- 1.57
- P/B
- 2.77
- EV/EBITDA
- 7.67
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 74.46%
- Op Margin
- 12.98%
- Net Margin
- 10.73%
- ROE
- 20.37%
- ROIC
- 17.12%
Growth & Income
- Revenue
- $228.37M · -0.91%
- Net Income
- $31.11M · 2.75%
- EPS
- $0.62 · 0.00%
- Op Income
- $37.30M
- FCF YoY
- 7.38%
Performance & Tape
- 52W High
- $7.90
- 52W Low
- $3.03
- 50D MA
- $6.93
- 200D MA
- $5.87
- Beta
- 1.23
- Avg Volume
- 348.44K
Get TickerSpark's AI analysis on PBYI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 18, 26 | AUERBACH ALAN H | other | 159,778 |
| Feb 18, 26 | AUERBACH ALAN H | other | 227,474 |
| Feb 18, 26 | HUNT DOUGLAS M | other | 49,394 |
| Feb 18, 26 | HUNT DOUGLAS M | other | 70,321 |
| Feb 18, 26 | NOUGUES MAXIMO F | other | 46,739 |
| Feb 18, 26 | NOUGUES MAXIMO F | other | 66,541 |
| Jan 6, 26 | AUERBACH ALAN H | sell | 16,938 |
| Jan 7, 26 | AUERBACH ALAN H | sell | 18,012 |
| Jan 6, 26 | HUNT DOUGLAS M | sell | 3,973 |
| Jan 7, 26 | HUNT DOUGLAS M | sell | 5,014 |
Our PBYI Coverage
We haven't published any research on PBYI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PBYI Report →